4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-26-000129
CEO & President sold 40,000 shares at an average $493.47 ($19,738,855)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Kewalramani Reshma · CEO & President
Table I: Non-derivative
13 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-27 | Sale : show line 1 in the form 10b5-1 | −400 | $479.75 | $191,900 | 137,878 | D |
| 2026-02-27 | Sale : show line 2 in the form 10b5-1 | −120 | $481.50 | $57,780 | 137,758 | D |
| 2026-02-27 | Sale : show line 3 in the form 10b5-1 | −240 | $482.84 | $115,882 | 137,518 | D |
| 2026-02-27 | Sale : show line 4 in the form 10b5-1 | −2,510 | $487.13 | $1,222,696 | 135,008 | D |
| 2026-02-27 | Sale : show line 5 in the form 10b5-1 | −3,278 | $488.27 | $1,600,549 | 131,730 | D |
| 2026-02-27 | Sale : show line 6 in the form 10b5-1 | −460 | $489.32 | $225,087 | 131,270 | D |
| 2026-02-27 | Sale : show line 7 in the form 10b5-1 | −2,725 | $490.54 | $1,336,722 | 128,545 | D |
| 2026-02-27 | Sale : show line 8 in the form 10b5-1 | −949 | $491.30 | $466,244 | 127,596 | D |
| Open-market sales · 40,000 sh · avg $493.47 · $19,738,855 | ||||||
Loading xslF345X05/wk-form4_1772573657.xml…